Breaking News Instant updates and real-time market news.

2020-04-22 06:32:17 WWW Wolverine World Wide $18.87 / +0.56 (+3.06%) 06:32 04/22/20 04/22 06:32 04/22/20 06:32	Wolverine World Wide reports Q1 adjusted EPS 28c, consensus 17c Reports Q1 revenue $439.3M, consensus $455.2M. Q1 reported revenue was down 16.1% versus the prior year. On a constant currency basis, revenue was down 15.6% versus the prior year.	22 Apr 30 Apr
WWW Wolverine World Wide $18.87 / +0.56 (+3.06%) 02/26/20 Susquehanna Wolverine World Wide price target lowered to $33 from $37 at Susquehanna 02/03/20 Susquehanna Wolverine World Wide compelling setup in Q4 results, says Susquehanna 11/18/19 Fly Intel: Top five analyst upgrades 11/18/19 Argus Wolverine World Wide upgraded to Buy from Hold at Argus

2020-04-22 06:32:17

WWW

Wolverine World Wide

$18.87 / +0.56 (+3.06%)

06:32

04/22/20

04/22

06:32

04/22/20

06:32

Wolverine World Wide reports Q1 adjusted EPS 28c, consensus 17c

Reports Q1 revenue $439.3M, consensus $455.2M. Q1 reported revenue was down 16.1% versus the prior year. On a constant currency basis, revenue was down 15.6% versus the prior year.

22
Apr
30
Apr

WWW Wolverine World Wide

$18.87 / +0.56 (+3.06%)

02/26/20 Susquehanna: Wolverine World Wide price target lowered to $33 from $37 at Susquehanna

02/03/20 Susquehanna: Wolverine World Wide compelling setup in Q4 results, says Susquehanna

11/18/19: Fly Intel: Top five analyst upgrades

11/18/19 Argus: Wolverine World Wide upgraded to Buy from Hold at Argus

TODAY'S FREE FLY STORIES

Earnings	Opiant Pharmaceuticals reports Q4 EPS (16c), consensus 7c » 16:42 03/04/21 03/04 16:42 03/04/21 16:42 OPNT Opiant Pharmaceuticals $12.25 / -0.82 (-6.27%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events OPNT Opiant Pharmaceuticals $12.25 / -0.82 (-6.27%) 02/08/21 Opiant says First patient dosed in confirmatory PK study of PNT003 12/14/20 Opiant announces additional commitment of up to $3.5M from BARDA 10/29/20 Opiant partners with Aptar Pharma on nasal nalmefen for opiod overdose OPNT Opiant Pharmaceuticals $12.25 / -0.82 (-6.27%) 11/12/20 Opiant Pharmaceuticals reports Q3 EPS 15c, consensus (21c) OPNT Opiant Pharmaceuticals $12.25 / -0.82 (-6.27%) 12/14/20 Fly Intel: After-Hours Movers 16:30 Today Opiant Pharmaceuticals - OPNT
Earnings	Alphatec reports Q4 EPS (35c), consensus (21c) » 16:39 03/04/21 03/04 16:39 03/04/21 16:39 ATEC Alphatec $15.86 / -0.69 (-4.17%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ATEC Alphatec $15.86 / -0.69 (-4.17%) 02/01/21 Alphatec relocates to new headquarters in Carlsbad 12/17/20 Alphatec to acquire EOS imaging for $79.7M in cash, sees accretion ATEC Alphatec $15.86 / -0.69 (-4.17%) 01/29/21 Piper Sandler Alphatec price target raised to $17 from $12 at Piper Sandler 01/12/21 Piper Sandler Piper remains buyer of Alphatec despite Covid pressures 12/21/20 H.C. Wainwright Alphatec price target raised to $16 from $12 at H.C. Wainwright 12/18/20 Lake Street Alphatec price target raised to $20 from $15 at Lake Street ATEC Alphatec $15.86 / -0.69 (-4.17%) 01/12/21 Alphatec sees 2021 revenue approximately $178M, consensus $183.08M 01/12/21 Alphatec sees 2020 revenue $144.8M-$145.1M, consensus $144.13M 01/12/21 Alphatec sees Q4 revenue $43.8M-$44.1M, consensus $43.66M 11/05/20 Alphatec sees FY20 revenue $143.5M-$146.0M, consensus $140.14M 14 Oct ATEC Alphatec $15.86 / -0.69 (-4.17%) 10/19/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers 10/08/20 Fly Intel: Wall Street's top stories for Thursday 10/08/20 Fly Intel: Wall Street's top stories at midday 16:30 Today Alphatec - ATEC 03/08/21 Alphatec
Earnings	T2 Biosystems sees FY21 revenue $24M-$26M, consensus $33.27M » 16:38 03/04/21 03/04 16:38 03/04/21 16:38 TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) The Company expects full… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/04/21 T2 Biosystems T2SARS-CoV can detect Brazil P.1 variant SARS-CoV 2 virus 01/11/21 T2 Biosystems: T2SARS-CoV-2 Panel can detect multiple variants of COVID-19 01/07/21 T2 Biosystems appoints Aparna Ahuja as CMO 10/19/20 Sepsis Alliance elects T2 Biosystems CEO as board member TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 01/27/21 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 11/05/20 Alliance Global Partners T2 Biosystems price target raised to $2.60 from $1.65 at Alliance Global 10/07/20 BTIG T2 Biosystems initiated with a Buy at BTIG 09/30/20 JonesTrading JonesTrading reiterates $3.50 target on T2 Biosystems after BARDA contract TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 16:34 Today T2 Biosystems reports Q4 EPS (7c), consensus (7c) 01/26/21 T2 Biosystems sees FY20 revenue $18.1M, consensus $19.32M 01/26/21 T2 Biosystems sees Q4 revenue $7.8M, consensus $9.01M TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/05/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: After-Hours Movers 01/12/21 Fly Intel: Pre-market Movers 16:30 Today T2 Biosystems - TTOO TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 15:34 Today T2 Biosystems options imply 26.4% move in share price post-earnings 02/10/21 Largest borrow rate increases among liquid names 01/12/21 Unusually active option classes on open January 12th 10/06/20 Largest borrow rate increases among liquid names
Conference/Events	Vonage to host virtual investor day » 16:38 03/04/21 03/04 16:38 03/04/21 16:38 VG Vonage $12.70 / -0.59 (-4.44%) Virtual Investor Day to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VG Vonage $12.70 / -0.59 (-4.44%) 02/18/21 Vonage terminates sale process of Consumer segment 01/28/21 Vonage appoints Stephen Lasher as CFO 01/14/21 Vonage names Jay Bellissimo as COO 12/01/20 Vonage announces strategic partnership with Yameo VG Vonage $12.70 / -0.59 (-4.44%) 01/04/21 Stephens Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens 11/12/20 Citi Citi adds Vonage to '90-day Catalyst Watch list' 10/02/20 Northland Twilio comments positive for Kaleyra, LivePerson and Vonage, says Northland 08/18/20 Fly Intel: Top five analyst downgrades VG Vonage $12.70 / -0.59 (-4.44%) 02/18/21 Vonage sees FY21 revenue $1.323B-$1.339B, consensus $1.31B 02/18/21 Vonage sees Q1 revenue $314M-$318M, consensus $308.7M 02/18/21 Vonage reports Q4 adjusted EPS 2c, consensus 5c 02/17/21 Notable companies reporting before tomorrow's open VG Vonage $12.70 / -0.59 (-4.44%) 02/18/21 Fly Intel: Pre-market Movers 03/10/21 2nd Annual Enterprise Comms Virtual Summit 03/05/21 Vonage Holdings Corp.
Hot Stocks	Waitr Holdings jumps 24% to $3.70 after expanding into cannabis delivery 16:36 03/04/21 03/04 16:36 03/04/21 16:36 WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) 16:35 Today Waitr Holdings expands into cannabis market 02/22/21 Waitr Holdings to integrate with Ordermark 11/17/20 Waitr Holdings' Ortale acquires over 266,000 common shares 10/08/20 Waitr Holdings shares move up after announcing the addition of dine in function WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) 11/10/20 B. Riley Securities Waitr Holdings price target lowered to $7 from $8 at B. Riley Securities 07/22/20 B. Riley FBR B. Riley FBR starts Waitr at Buy, calls attractive takeout candidate 07/22/20 B. Riley FBR Waitr Holdings initiated with a Buy at B. Riley FBR 07/09/20 Deutsche Bank Waitr Holdings downgraded to Hold on valuation at Deutsche Bank WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) 11/09/20 Waitr Holdings reports Q3 EPS 4c, consensus 5c WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) 11/18/20 Fly Intel: Pre-market Movers 03/08/21 Waitr Holdings - WTRH

Hot Stocks	Waitr Holdings expands into cannabis market » 16:35 03/04/21 03/04 16:35 03/04/21 16:35 WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) The company states:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) 02/22/21 Waitr Holdings to integrate with Ordermark 11/17/20 Waitr Holdings' Ortale acquires over 266,000 common shares 10/08/20 Waitr Holdings shares move up after announcing the addition of dine in function WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) 11/10/20 B. Riley Securities Waitr Holdings price target lowered to $7 from $8 at B. Riley Securities 07/22/20 B. Riley FBR B. Riley FBR starts Waitr at Buy, calls attractive takeout candidate 07/22/20 B. Riley FBR Waitr Holdings initiated with a Buy at B. Riley FBR 07/09/20 Deutsche Bank Waitr Holdings downgraded to Hold on valuation at Deutsche Bank WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) 11/09/20 Waitr Holdings reports Q3 EPS 4c, consensus 5c WTRH Waitr Holdings $2.99 / -0.19 (-5.97%) 11/18/20 Fly Intel: Pre-market Movers 03/08/21 Waitr Holdings - WTRH
Earnings	T2 Biosystems reports Q4 EPS (7c), consensus (7c) » 16:34 03/04/21 03/04 16:34 03/04/21 16:34 TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) Reports Q4 revenue $7.8M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/04/21 T2 Biosystems T2SARS-CoV can detect Brazil P.1 variant SARS-CoV 2 virus 01/11/21 T2 Biosystems: T2SARS-CoV-2 Panel can detect multiple variants of COVID-19 01/07/21 T2 Biosystems appoints Aparna Ahuja as CMO 10/19/20 Sepsis Alliance elects T2 Biosystems CEO as board member TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 01/27/21 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 11/05/20 Alliance Global Partners T2 Biosystems price target raised to $2.60 from $1.65 at Alliance Global 10/07/20 BTIG T2 Biosystems initiated with a Buy at BTIG 09/30/20 JonesTrading JonesTrading reiterates $3.50 target on T2 Biosystems after BARDA contract TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 01/26/21 T2 Biosystems sees FY20 revenue $18.1M, consensus $19.32M 01/26/21 T2 Biosystems sees Q4 revenue $7.8M, consensus $9.01M TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/05/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: After-Hours Movers 01/12/21 Fly Intel: Pre-market Movers 16:30 Today T2 Biosystems - TTOO TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 15:34 Today T2 Biosystems options imply 26.4% move in share price post-earnings 02/10/21 Largest borrow rate increases among liquid names 01/12/21 Unusually active option classes on open January 12th 10/06/20 Largest borrow rate increases among liquid names
General news	Fed Balance Sheet Level data reported » 16:34 03/04/21 03/04 16:34 03/04/21 16:34 Week of 3/3 Fed Balance… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Smith & Wesson Brands jumps 5% to $16.64 after Q3 results beat estimates 16:33 03/04/21 03/04 16:33 03/04/21 16:33 SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 16:26 Today Smith & Wesson Brands reports Q3 gross margin 42.6% vs. 28% last year 16:07 Today Smith & Wesson Brands announces $100M share repurchase plan 03/03/21 FBI reports 3.44M NICS firearm background checks in February 01/06/21 Firearms makers up amid Capitol protests, lockdown SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 08:49 Today B. Riley Securities B. Riley starts American Outdoor Brands with Buy, $32 price target 12/04/20 Lake Street Lake Street ups Smith & Wesson Brands price target to $28 after earnings 10/05/20 B. Riley Securities Firearm demand has seen meaningful uptick, says B. Riley Securities 09/24/20 Fly Intel: Top five analyst initiations SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 16:06 Today Smith & Wesson Brands reports Q3 EPS $1.12, consensus 76c 12/03/20 Smith & Wesson Brands reports Q2 adjusted EPS 93c, consensus 63c SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 12/15/20 Smith & Wesson sues New Jersey to block subpoena related to marketing, WSJ says SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 12/16/20 Fly Intel: After-Hours Movers 12/03/20 Fly Intel: After-Hours Movers 17:00 Today Smith & Wesson Brands - SWBI SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 02/18/21 Smith and Wesson call volume above normal and directionally bullish 02/03/21 Smith and Wesson put volume heavy and directionally bearish 01/27/21 Smith and Wesson put volume heavy and directionally bearish 01/11/21 Smith and Wesson call volume above normal and directionally bullish
Hot Stocks	Opendoor sees Q1 sequential growth over Q420 at the midpoint of expected range » 16:33 03/04/21 03/04 16:33 03/04/21 16:33 OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) First quarter 2021… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 12/29/20 SB Investment Advisers reports 13.5% passive stake in Opendoor Technologies 12/18/20 Opendoor to become publicly-traded following Social Capital deal 12/17/20 Social Capital Hedosophia approves business combination with Opendoor OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 03/01/21 Credit Suisse Opendoor Technologies initiated with an Outperform at Credit Suisse 02/19/21 Fly Intel: Top five analyst initiations 02/19/21 KeyBanc Opendoor Technologies initiated with an Overweight at KeyBanc 01/06/21 Wedbush Wedbush bullish on Opendoor Technologies, initiates with an Outperform OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 16:30 Today Opendoor Technologies reports Q 4EPS (49c), consensus (10c) 05 Feb OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 02/05/21 Opendoor 'shouldn't be afraid to show its work,' WSJ says OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 02/02/21 Fly Intel: After-Hours Movers 12/21/20 Microsoft, Walmart upgrades among today's top calls on Wall Street 17:00 Today Opendoor Technologies - OPEN OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 02/03/21 Opendoor Technologies call volume above normal and directionally bullish 01/22/21 Largest borrow rate increases among liquid names 01/21/21 Largest borrow rate increases among liquid names 01/20/21 Largest borrow rate increases among liquid names

Earnings	NGM Biopharmaceuticals reports Q4 EPS (40c), consensus (47c) » 16:32 03/04/21 03/04 16:32 03/04/21 16:32 NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 03/02/21 NGM Biopharmaceuticals initiates expansion of Phase 1b study of NGM120 12/09/20 NGM Biopharmaceuticals announces NGM438 featured during R&D Day 11/13/20 NGM Biopharmaceuticals presents Phase 1 safety, PK data for NGM621 10/19/20 NGM announces immuno-oncology development candidate NGM707 NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 02/09/21 Goldman Sachs NGM Biopharmaceuticals price target raised to $38 from $28 at Goldman Sachs 01/08/21 Raymond James NGM Biopharmaceuticals price target raised to $50 from $32 at Raymond James 01/05/21 Stifel NGM Biopharmaceuticals named a top pick, price target boosted to $43 at Stifel 12/21/20 Citi NGM Biopharmaceuticals price target raised to $44 from $28 at Citi NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 11/12/20 NGM Biopharmaceuticals reports Q3 EPS (43c), consensus (38c) 06 Jan NGM NGM Biopharmaceuticals $27.10 / -1.36 (-4.78%) 01/04/21 Fly Intel: After-Hours Movers 03/02/21 41st Annual Healthcare Virtual Conference
Hot Stocks	Asur reports February total passenger traffic down 49.2% » 16:32 03/04/21 03/04 16:32 03/04/21 16:32 ASR Asur $174.73 / -7.99 (-4.37%) Asur announced that total… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ASR Asur $174.73 / -7.99 (-4.37%) 02/24/21 Asur reports Q4 passenger traffic down 44.9% y/y 02/04/21 Asur reports January traffic down 43.7% from last year 01/06/21 Asur reports December passenger traffic down 41.2% y/y 12/03/20 Asur reports November passenger traffic down 44.4% y/y ASR Asur $174.73 / -7.99 (-4.37%) 12/23/20 Citi Airline demand in early 2021 'looks soft,' says Citi 12/04/20 Scotiabank Asur downgraded to Underperform from Sector Perform at Scotiabank 10/07/20 Citi Asur downgraded to Neutral on hurricane risk at Citi (yesterday) 10/06/20 Citi Asur downgraded to Neutral from Buy at Citi ASR Asur $174.73 / -7.99 (-4.37%) 02/24/21 Asur reports Q4 EBITDA down 45.4% to MXN1.33B
Hot Stocks	LGL Group increases capability, capacity investments in UAS development » 16:32 03/04/21 03/04 16:32 03/04/21 16:32 LGL LGL Group $12.33 / -0.35 (-2.76%) The LGL Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Events 03/24/21 LGL Group - LGL
Earnings	Opendoor Technologies reports Q 4EPS (49c), consensus (10c) » 16:30 03/04/21 03/04 16:30 03/04/21 16:30 OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Periodicals On The Fly Events Options OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 12/29/20 SB Investment Advisers reports 13.5% passive stake in Opendoor Technologies 12/18/20 Opendoor to become publicly-traded following Social Capital deal 12/17/20 Social Capital Hedosophia approves business combination with Opendoor OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 03/01/21 Credit Suisse Opendoor Technologies initiated with an Outperform at Credit Suisse 02/19/21 Fly Intel: Top five analyst initiations 02/19/21 KeyBanc Opendoor Technologies initiated with an Overweight at KeyBanc 01/06/21 Wedbush Wedbush bullish on Opendoor Technologies, initiates with an Outperform 05 Feb OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 02/05/21 Opendoor 'shouldn't be afraid to show its work,' WSJ says OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 02/02/21 Fly Intel: After-Hours Movers 12/21/20 Microsoft, Walmart upgrades among today's top calls on Wall Street 17:00 Today Opendoor Technologies - OPEN OPEN Opendoor Technologies $24.40 / -4.46 (-15.45%) 02/03/21 Opendoor Technologies call volume above normal and directionally bullish 01/22/21 Largest borrow rate increases among liquid names 01/21/21 Largest borrow rate increases among liquid names 01/20/21 Largest borrow rate increases among liquid names
Hot Stocks	Imax jumps 7% to $22.10 after Q4 results beat estimates 16:30 03/04/21 03/04 16:30 03/04/21 16:30 IMAX Imax $20.78 / -0.98 (-4.50%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IMAX Imax $20.78 / -0.98 (-4.50%) 02/22/21 Movie theater operators jump as Gov. Cuomo gives greenlight to NYC reopening 02/10/21 iQIYI Launches Imax Enhanced in China 12/22/20 Sony Pictures CEO says 'don't think' will move to 'day and date' film releases 12/17/20 Imax, JinYi Media announce new 12-theatre agreement IMAX Imax $20.78 / -0.98 (-4.50%) 03/01/21 Wedbush Imax price target raised to $22 from $14 at Wedbush 02/16/21 B. Riley Securities IMAX format positioned to gain post-pandemic share, says B. Riley Securities 02/16/21 Macquarie Imax remains best way to play theatrical space, says Macquarie 02/15/21 Benchmark Benchmark boosts Imax target to $22, says movie goers will return IMAX Imax $20.78 / -0.98 (-4.50%) 16:12 Today Imax reports Q4 adjusted EPS (21c), consensus (20c) 10/29/20 Imax reports Q3 EPS (75c), consensus (30c) IMAX Imax $20.78 / -0.98 (-4.50%) 02/22/21 Movie theaters might get OK to reopen in New York City, Deadline says 10/18/20 NY state moves to reopen movie theaters, ski resorts, Bloomberg reports 10/08/20 Imax furloughs 150 employees in U.S., Variety reports IMAX Imax $20.78 / -0.98 (-4.50%) 12/28/20 AMC, Cinemark rise as WW84 scores highest box office opening of pandemic 12/03/20 Fly Intel: Wall Street's top stories for Thursday 11/24/20 Fly Intel: Wall Street's top stories for Tuesday 16:30 Today Imax - IMAX IMAX Imax $20.78 / -0.98 (-4.50%) 01/05/21 Largest borrow rate increases among liquid names 11/10/20 IMAX call buyer realizes 525% same-day gains 10/23/20 Largest borrow rate increases among liquid names 09/23/20 Unusual call flow in option market yesterday

Options	Preliminary option volume of 53.9M today » 16:30 03/04/21 03/04 16:30 03/04/21 16:30 Preliminary option volume… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Earnings	Jamf Holding sees FY21 revenue $330M-$336M, consensus $316.41M » 16:29 03/04/21 03/04 16:29 03/04/21 16:29 JAMF Jamf Holding $36.45 / -1.33 (-3.52%) Sees FY21 operating… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 03/01/21 Jamf acquires security, compliance solutions created by cmdSecurity 02/01/21 Jamf Holding COO, CFO sell 60.7K shares and 6.3K shares in common stock 01/04/21 Jamf Holding announces it is running on more than 20M Apple devices 11/16/20 Tiger Global adds Snowflake, GSX and BigCommerce during Q3 JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 01/28/21 Piper Sandler Jamf Holding remains a top idea for 2021 at Piper Sandler 01/05/21 Canaccord Jamf Holding metrics 'bode well' for strong Q4, says Canaccord 09/02/20 Canaccord Jamf Holding upside likely in Q3, says Canaccord 08/17/20 Fly Intel: Top five analyst initiations JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 16:28 Today Jamf Holding sees Q1 revenue $76M-$77M, consensus $72.44M 16:26 Today Jamf Holding reports Q4 EPS (8c), consensus 1c 19 Nov 22 Jul 16:30 Today Jamf Holding - JAMF 03/08/21 Jamf Holding
Hot Stocks	MMA Capital names Gary Mentesana as CEO, Michael Falcone as board Chairman » 16:29 03/04/21 03/04 16:29 03/04/21 16:29 MMAC MMA Capital $21.79 / -0.51 (-2.29%) MMA Capital reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Synthetic Biologics sees cash on hand sufficient into 2023 » 16:28 03/04/21 03/04 16:28 03/04/21 16:28 SYN Synthetic Biologics $0.58 / -0.0649 (-10.06%) Synthetic Biologics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SYN Synthetic Biologics $0.58 / -0.0649 (-10.06%) 12/22/20 Synthetic Biologics: IRB at Washington University approves trial of SYN-004 11/24/20 Synthetic Biologics granted extension of compliance plan by NYSE American 11/16/20 Synthetic Biologics engages AGP as advisor to assist in evaluationg options 10/02/20 Synthetic Biologics: CSMC to discontinue Phase 2b clinical study of SYN-010 SYN Synthetic Biologics $0.58 / -0.0649 (-10.06%) 10/02/20 Maxim Synthetic Biologics downgraded to Hold from Buy at Maxim 06/18/20 Maxim Synthetic Biologics initiated with a Buy at Maxim 05/06/20 Alliance Global Partners Synthetic Biologics price target lowered to $1.25 from $2.25 at Alliance Global SYN Synthetic Biologics $0.58 / -0.0649 (-10.06%) 11/10/20 Synthetic Biologics reports Q3 EPS (14c), consensus (17c) 16:30 Today Synthetic Biologics - SYN
Earnings	Jamf Holding sees Q1 revenue $76M-$77M, consensus $72.44M » 16:28 03/04/21 03/04 16:28 03/04/21 16:28 JAMF Jamf Holding $36.45 / -1.33 (-3.52%) Sees Q1 operating income… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 03/01/21 Jamf acquires security, compliance solutions created by cmdSecurity 02/01/21 Jamf Holding COO, CFO sell 60.7K shares and 6.3K shares in common stock 01/04/21 Jamf Holding announces it is running on more than 20M Apple devices 11/16/20 Tiger Global adds Snowflake, GSX and BigCommerce during Q3 JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 01/28/21 Piper Sandler Jamf Holding remains a top idea for 2021 at Piper Sandler 01/05/21 Canaccord Jamf Holding metrics 'bode well' for strong Q4, says Canaccord 09/02/20 Canaccord Jamf Holding upside likely in Q3, says Canaccord 08/17/20 Fly Intel: Top five analyst initiations JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 16:26 Today Jamf Holding reports Q4 EPS (8c), consensus 1c 19 Nov 22 Jul 16:30 Today Jamf Holding - JAMF 03/08/21 Jamf Holding

Syndicate	Paramount Group files automatic mixed securities shelf 16:27 03/04/21 03/04 16:27 03/04/21 16:27 PGRE Paramount Group $9.54 / -0.215 (-2.20%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PGRE Paramount Group $9.54 / -0.215 (-2.20%) 11/17/20 Paramount Group CEO buys 20K shares of common stock 11/17/20 Paramount Group rises 17.0% 11/17/20 Paramount Group rises 10.6% 11/17/20 Paramount Group rises 14.8% PGRE Paramount Group $9.54 / -0.215 (-2.20%) 01/11/21 Mizuho Paramount Group downgraded to Underperform from Neutral at Mizuho 12/10/20 Wells Fargo Paramount Group downgraded to Underweight at Wells Fargo 12/10/20 Wells Fargo Paramount Group downgraded to Underweight from Overweight at Wells Fargo 10/19/20 Evercore ISI Paramount Group downgraded to In Line from Outperform at Evercore ISI PGRE Paramount Group $9.54 / -0.215 (-2.20%) 02/10/21 Paramount Group sees FY21 core FFO 82c-88c, consensus 83c 02/10/21 Paramount Group reports Q4 core FFO 24c, consensus 23c 10/28/20 Paramount Group reports Q3 core FFO 22c, consensus 23c PGRE Paramount Group $9.54 / -0.215 (-2.20%) 11/17/20 Fly Intel: Wall Street's top stories for Tuesday 11/17/20 Fly Intel: Wall Street's top stories at midday 10/14/20 Fly Intel: Pre-market Movers 03/25/21 REITwise 2021 Virtual Conference
Hot Stocks	Smith & Wesson Brands reports Q3 gross margin 42.6% vs. 28% last year 16:26 03/04/21 03/04 16:26 03/04/21 16:26 SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 16:07 Today Smith & Wesson Brands announces $100M share repurchase plan 03/03/21 FBI reports 3.44M NICS firearm background checks in February 01/06/21 Firearms makers up amid Capitol protests, lockdown 01/04/21 FBI reports 3.94M NICS firearm background checks in December SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 08:49 Today B. Riley Securities B. Riley starts American Outdoor Brands with Buy, $32 price target 12/04/20 Lake Street Lake Street ups Smith & Wesson Brands price target to $28 after earnings 10/05/20 B. Riley Securities Firearm demand has seen meaningful uptick, says B. Riley Securities 09/24/20 Fly Intel: Top five analyst initiations SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 16:06 Today Smith & Wesson Brands reports Q3 EPS $1.12, consensus 76c 12/03/20 Smith & Wesson Brands reports Q2 adjusted EPS 93c, consensus 63c SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 12/15/20 Smith & Wesson sues New Jersey to block subpoena related to marketing, WSJ says SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 12/16/20 Fly Intel: After-Hours Movers 12/03/20 Fly Intel: After-Hours Movers 17:00 Today Smith & Wesson Brands - SWBI SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 02/18/21 Smith and Wesson call volume above normal and directionally bullish 02/03/21 Smith and Wesson put volume heavy and directionally bearish 01/27/21 Smith and Wesson put volume heavy and directionally bearish 01/11/21 Smith and Wesson call volume above normal and directionally bullish
Earnings	Joint Corp. sees FY21 revenue $73M-$77M , consensus $72.23M 16:26 03/04/21 03/04 16:26 03/04/21 16:26 JYNT Joint Corp. $44.28 / -4.77 (-9.72%) ShowHide Related Items >><< Company News Street Research Earnings Events JYNT Joint Corp. $44.28 / -4.77 (-9.72%) 01/05/21 Joint Corp. acquires two regional developer territories for $2.4M JYNT Joint Corp. $44.28 / -4.77 (-9.72%) 02/25/21 B. Riley Securities Joint Corp. price target raised to $47 from $26 at B. Riley Securities 01/06/21 Craig-Hallum Joint Corp. price target raised to $38 from $26 at Craig-Hallum 01/04/21 Lake Street Joint Corp. price target raised to $35 from $25 at Lake Street 11/06/20 B. Riley Securities Joint Corp. price target raised to $26 from $22 at B. Riley Securities JYNT Joint Corp. $44.28 / -4.77 (-9.72%) 16:24 Today Joint Corp. reports Q4 EPS 72c, consensus 14c 11/05/20 Joint Corp. reports Q3 EPS 11c, consensus 2c 03/15/21 33rd Annual Roth Virtual Conference 17:00 Today Joint Corp. - JYNT
Hot Stocks	ON Semiconductor to cut 740 jobs, take associated charge of $58M-$62M in H1 » 16:26 03/04/21 03/04 16:26 03/04/21 16:26 ON ON Semiconductor $36.99 / -2.69 (-6.78%) The company states:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ON ON Semiconductor $36.99 / -2.69 (-6.78%) 02/16/21 Starboard Value buys ON Semi, cuts Advance Auto stake in Q4 01/28/21 ON Semiconductor announces Thad Trent as CFO 01/15/21 ON Semiconductor COO William Schromm to step down 12/07/20 ON Semiconductor names Hassane El-Khoury CEO ON ON Semiconductor $36.99 / -2.69 (-6.78%) 03/01/21 BofA BofA double upgrades ON Semi on autos tailwinds, restructuring potential 03/01/21 BofA ON Semiconductor upgraded to Buy from Underperform at BofA 02/10/21 B. Riley Securities B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion 02/02/21 JPMorgan ON Semiconductor price target raised to $37.50 from $25.50 at JPMorgan ON ON Semiconductor $36.99 / -2.69 (-6.78%) 02/01/21 ON Semiconductor sees Q1 revenue $1.41B-$1.51B, consensus $1.35B 02/01/21 ON Semiconductor reports Q4 EPS 35c, consensus 28c 11/01/20 ON Semiconductor sees Q4 revenue $1.3B-$1.4B, consensus $1.31B 11/01/20 ON Semiconductor reports Q3 EPS 27c, consensus 20c ON ON Semiconductor $36.99 / -2.69 (-6.78%) 10/09/20 Starboard makes new bets on Corteva, ON Semiconductor, Reuters reports ON ON Semiconductor $36.99 / -2.69 (-6.78%) 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street ON ON Semiconductor $36.99 / -2.69 (-6.78%) 02/12/21 Unusually active option classes on open February 12th 02/09/21 ON Semiconductor call volume above normal and directionally bullish 02/09/21 Unusually active option classes on open February 9th 10/02/20 Unusual call flow in option market yesterday
Earnings	Jamf Holding reports Q4 EPS (8c), consensus 1c » 16:26 03/04/21 03/04 16:26 03/04/21 16:26 JAMF Jamf Holding $36.45 / -1.33 (-3.52%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 03/01/21 Jamf acquires security, compliance solutions created by cmdSecurity 02/01/21 Jamf Holding COO, CFO sell 60.7K shares and 6.3K shares in common stock 01/04/21 Jamf Holding announces it is running on more than 20M Apple devices 11/16/20 Tiger Global adds Snowflake, GSX and BigCommerce during Q3 JAMF Jamf Holding $36.45 / -1.33 (-3.52%) 01/28/21 Piper Sandler Jamf Holding remains a top idea for 2021 at Piper Sandler 01/05/21 Canaccord Jamf Holding metrics 'bode well' for strong Q4, says Canaccord 09/02/20 Canaccord Jamf Holding upside likely in Q3, says Canaccord 08/17/20 Fly Intel: Top five analyst initiations 19 Nov 22 Jul 16:30 Today Jamf Holding - JAMF 03/08/21 Jamf Holding

Events

Earnings calls, analyst events, roadshows and more

ANIK
Today at 17:00

Anika Therapeutics - ANIK Conference Calls
OPEN
Today at 17:00

Opendoor Technologies - OPEN Conference Calls
TRIN
Today at 17:00

Trinity Capital - TRIN Conference Calls
AGS
Today at 17:00

PlayAGS - AGS Conference Calls
COST
Today at 17:00

Costco - COST Conference Calls
INVE
Today at 17:00

Identiv - INVE Conference Calls
JYNT
Today at 17:00

Joint Corp. - JYNT Conference Calls
GPS
Today at 17:00

Gap - GPS Conference Calls
CHMA
Today at 17:00

Chiasma - CHMA Conference Calls
AVGO
Today at 17:00

Broadcom - AVGO Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital $149.49 7M Shares
Fri	No deals

View All Syndicate Announcements »

Wolverine World Wide reports Q1 adjusted EPS 28c, consensus 17c

TODAY'S FREE FLY STORIES

Get Full Fly Access